At a time when ongoing research and clinical investigation into the use of HRT in perimenopausal women are incomplete--and when certain controversies remain unresolved--this summary of current opinion and knowledge fills the need for authoritative reference on this topic. Written by a 'Blue Ribbon' panel, the book addresses the wide range of advances in clinical practice for the climacteric in diagnostic technology and to therapeutic choices. In order to provide optimal assistance in determining an individual women's risk-profile --and properly to assess the potential of therapeutic intervention--the biological and practical rationale of all existing HRT agents are reviewed. Key feature *Addresses the wide range of advances in clinical practice for the climacteric *Provides current opinion and information on the use of HRT in perimenopausal women *Reviews the biological and practical rationale of all existing HRT agents19. Breast. cancer. risk: differences. between. hormone. preparations? Table 1 Time course of the incidence of invasive breast ... The increase in the incidence of breast cancer observed in postmenopausal women during long-term hormone anbsp;...
|Title||:||Climacteric Medicine - Where Do We Go?|
|Author||:||Hermann P.G. Schneider, Frederick Naftolin|
|Publisher||:||CRC Press - 2004-09-22|